You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Kuvan Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Kuvan, and when can generic versions of Kuvan launch?

Kuvan is a drug marketed by Biomarin Pharm and is included in two NDAs. There are ten patents protecting this drug and three Paragraph IV challenges.

This drug has one hundred and seventeen patent family members in twenty-six countries.

The generic ingredient in KUVAN is sapropterin dihydrochloride. There are three drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the sapropterin dihydrochloride profile page.

Paragraph IV (Patent) Challenges for KUVAN
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
KUVAN Powder for Oral Solution sapropterin dihydrochloride 500 mg per packet 205065 1 2017-02-23
KUVAN Powder for Oral Solution sapropterin dihydrochloride 100 mg per packet 205065 1 2015-11-09
KUVAN Tablets sapropterin dihydrochloride 100 mg 022181 1 2014-06-05

US Patents and Regulatory Information for Kuvan

Kuvan is protected by six US patents.

Patents protecting Kuvan

Methods and compositions for the treatment of metabolic disorders
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Methods and compositions for the treatment of metabolic disorders
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Dry blend formulation of tetrahydrobiopterin
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Methods and compositions for the treatment of metabolic disorders
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Methods of administering tetrahydrobiopterin
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biomarin Pharm KUVAN sapropterin dihydrochloride POWDER;ORAL 205065-001 Dec 19, 2013 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Biomarin Pharm KUVAN sapropterin dihydrochloride TABLET;ORAL 022181-001 Dec 13, 2007 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Biomarin Pharm KUVAN sapropterin dihydrochloride POWDER;ORAL 205065-002 Oct 27, 2015 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Biomarin Pharm KUVAN sapropterin dihydrochloride POWDER;ORAL 205065-001 Dec 19, 2013 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Biomarin Pharm KUVAN sapropterin dihydrochloride POWDER;ORAL 205065-002 Oct 27, 2015 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for Kuvan

When does loss-of-exclusivity occur for Kuvan?

Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:

Argentina

Patent: 2238
Estimated Expiration: ⤷  Try a Trial

Australia

Patent: 05306686
Estimated Expiration: ⤷  Try a Trial

Brazil

Patent: 0517088
Estimated Expiration: ⤷  Try a Trial

Canada

Patent: 81814
Estimated Expiration: ⤷  Try a Trial

China

Patent: 1132776
Estimated Expiration: ⤷  Try a Trial

European Patent Office

Patent: 45952
Estimated Expiration: ⤷  Try a Trial

Patent: 36379
Estimated Expiration: ⤷  Try a Trial

Israel

Patent: 2161
Estimated Expiration: ⤷  Try a Trial

Japan

Patent: 08520574
Estimated Expiration: ⤷  Try a Trial

Patent: 14012740
Estimated Expiration: ⤷  Try a Trial

Malaysia

Patent: 2120
Estimated Expiration: ⤷  Try a Trial

Mexico

Patent: 07005039
Estimated Expiration: ⤷  Try a Trial

Peru

Patent: 061294
Estimated Expiration: ⤷  Try a Trial

South Korea

Patent: 070084270
Estimated Expiration: ⤷  Try a Trial

Taiwan

Patent: 0624120
Estimated Expiration: ⤷  Try a Trial

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

See the table below for additional patents covering Kuvan around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 3461503 PROCÉDÉS D'ADMINISTRATION DE LA TÉTRAHYDROBIOPTÉRINE, COMPOSITIONS ASSOCIÉES ET PROCÉDÉS DE MESURE (METHODS OF ADMINISTERING TETRAHYDROBIOPTERIN, ASSOCIATED COMPOSITIONS, AND METHODS OF MEASURING) ⤷  Try a Trial
Portugal 2545939 ⤷  Try a Trial
Russian Federation 2470642 АНАЛОГИ ПТЕРИНА ДЛЯ ЛЕЧЕНИЯ СОСТОЯНИЯ, ЧУВСТВИТЕЛЬНОГО К ВН4 (PTERIN ANALOGUES FOR TREATING BH4 SENSITIVE CONDITION) ⤷  Try a Trial
Canada 2581814 FORMULE STABLE DE COMPRIMES (STABLE TABLET FORMULATION OF TETRAHYDROBIOPTERIN) ⤷  Try a Trial
Peru 20061294 FORMULACION DE TABLETA ESTABLE QUE CONTIENE POLIMORFO B DE (6R)-L-ERITRO-TETRA HIDROBIOPTERINA ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.